Details for Patent: 9,487,491
✉ Email this page to a colleague
Which drugs does patent 9,487,491 protect, and when does it expire?
Patent 9,487,491 protects XOSPATA and is included in one NDA.
This patent has forty-eight patent family members in twenty-nine countries.
Summary for Patent: 9,487,491
Title: | Diamino heterocyclic carboxamide compound |
Abstract: | Provided is a compound useful as an inhibitor against the kinase activity of EML4-ALK fusion protein. As a result of intensive and extensive studies on compounds having inhibitory activity against the kinase activity of EML4-ALK fusion protein, the present inventors found that the diamino heterocyclic carboxamide compounds of the present invention had inhibitory activity against the kinase activity of EML4-ALK fusion protein. By this finding, the present invention was completed. The compounds of the present invention can be used as a pharmaceutical composition for preventing and/or treating cancer, such as lung cancer, non-small cell lung cancer, and small cell lung cancer. |
Inventor(s): | Shimada; Itsuro (Chuo-ku, JP), Kurosawa; Kazuo (Chuo-ku, JP), Matsuya; Takahiro (Chuo-ku, JP), Iikubo; Kazuhiko (Chuo-ku, JP), Kondoh; Yutaka (Chuo-ku, JP), Kamikawa; Akio (Chuo-ku, JP), Tomiyama; Hiroshi (Chuo-ku, JP), Iwai; Yoshinori (Chuo-ku, JP) |
Assignee: | ASTELLAS PHARMA INC. (Tokyo, JP) KOTOBUKI PHARMACEUTICAL CO., LTD. (Nagano, JP) |
Application Number: | 14/472,959 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 9,487,491
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | XOSPATA | gilteritinib fumarate | TABLET;ORAL | 211349-001 | Nov 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,487,491
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2009-113936 | May 8, 2009 |
International Family Members for US Patent 9,487,491
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010245545 | ⤷ Try a Trial | |||
Brazil | PI1011838 | ⤷ Try a Trial | |||
Canada | 2760061 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |